Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Survival From Synchronous Bilateral Breast Cancer: The Experience of Surgeons Participating in the Breast Audit of the Society of Breast Surgeons of Australia and New Zealand

  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Previous studies generally indicate that synchronous bilateral breast cancers (SBBC) have an equivalent or moderately poorer survival compared with unilateral cases. The prognostic characteristics of SBBC would be relevant when planning adjuvant therapies and follow-up medical surveillance. The frequency of SBBC among early breast cancers in clinical settings in Australia and New Zealand was investigated, plus their prognostic significance, using the Breast Cancer Audit Database of the Society of Breast Surgeons of Australia and New Zealand, which covered an estimated 60% of early invasive lesions in those countries. Design: Rate ratios (95% confidence limits) of SBBC were investigated among 35,370 female breast cancer cases by age of woman, histology type, grade, tumour diameter, nodal status, lymphatic/vascular invasion and oestrogen receptor status. Univariate and multivariable disease-specific survival analyses were undertaken. Results: 2.3% of cases were found to be SBBC (i.e., diagnoses occurring within 3 months). The figure increased from 1.4% in women less than 40 years to 4.1% in those aged 80 years or more. Disease-specific survivals did not vary by SBBC status (p=0.206). After adjusting for age, histology type, diameter, grade, nodal status, lymphatic/vascular invasion, and oestrogen receptor status, the relative risk of breast cancer death for SBBC was 1.17 (95% CL: 0.91, 1.51). After adjusting for favourable prognostic factors more common in SBBC cases (i.e., histology type, grade, lymphatic/vascular invasion, and oestrogen receptor status), the relative risk of breast cancer death for SBBC was 1.42 (95% CL: 1.10, 1.82). After adjusting for unfavourable prognostic factors more common in SBBC cases (i.e., older age and large tumour diameter), the relative risk of breast cancer death for SBBC was 0.98 (95% CL: 0.76, 1.26). Conclusions: Results confirm previous findings of an equivalent or moderately poorer survival for SBBC but indicate that SBBC status is likely to be an important prognostic indicator for some cases.

Keywords

References

  1. AIHW (Australian Institute of Health and Welfare) (2010). Cancer in Australia 2010: an overview. Cancer series no. 60. Cat. No. CAN 56. AIHW, Canberra, Australia.
  2. Armitage P, Berry G (1987). Statistical methods in medical research. Blackwell Scientific Publications, Oxford.
  3. Beckmann KR, Buckingham J, Craft P, et al (2011). Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. The Breast, 20, 158-64. https://doi.org/10.1016/j.breast.2010.10.004
  4. Chen Y, Thompson W, Semenciw R, Mao Y (1999). Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev, 8, 855-61.
  5. Cook LS, White E, Schwartz SM, et al (1996). A population based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control, 7, 382-90. https://doi.org/10.1007/BF00052945
  6. Dawson LA, Chow E, Goss PE (1998). Evolving perspectives in contralateral breast cancer. Eur J Cancer, 34, 2000-9. https://doi.org/10.1016/S0959-8049(98)00208-1
  7. DeVita VT, Lawrence TS, Rosenberg SA, De Pinho RA, Weinberg RA (2008). Cancer: principles and practice of oncology. 8th Edition. Lippincott, Williams & Wilkins, Philadelphia.
  8. Garlinger PM, Abramson JH (1995). Computer programs for epidemiologic analysis. Unicorn Software Development, Inc., Stone Mountain, Georgia.
  9. Gollamudi SV, Gelman RS, Peiro G, et al (1997). Breastconserving therapy for stage I-II synchronous bilateral breast carcinoma. Cancer, 79, 1362-9. https://doi.org/10.1002/(SICI)1097-0142(19970401)79:7<1362::AID-CNCR14>3.0.CO;2-Y
  10. Hartman M, Czene K, Reilly M, et al (2007). Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol, 25, 4210-6. https://doi.org/10.1200/JCO.2006.10.5056
  11. Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM (2000). Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer, 88, 2739-50. https://doi.org/10.1002/1097-0142(20000615)88:12<2739::AID-CNCR12>3.0.CO;2-J
  12. Horn PL, Thompson WD (1988). Risk of contralateral breast cancer: associations with histologic, clinical and therapeutic factors. Cancer, 62, 412-24. https://doi.org/10.1002/1097-0142(19880715)62:2<412::AID-CNCR2820620228>3.0.CO;2-3
  13. Jobsen JJ, Van der Palen J, Ong F, Meerwaldt JH (2003). Synchronous, bilateral breast cancer: prognostic value and incidence. The Breast, 12, 83-8. https://doi.org/10.1016/S0960-9776(02)00278-3
  14. Kollias J, Ellis IO, Elston CW, Blamey RW (2001). Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg, 25, 1117-24. https://doi.org/10.1007/BF03215857
  15. Newman LA, Sahin AA, Cunningham JE, et al (2001). A casecontrol study of unilateral and bilateral breast carcinoma patients. Cancer, 91, 1845-53. https://doi.org/10.1002/1097-0142(20010515)91:10<1845::AID-CNCR1205>3.0.CO;2-Z
  16. Polednak AP (2003). Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery, 133, 383-9. https://doi.org/10.1067/msy.2003.110
  17. Ries LAG, Melbert D, Krapcho M, et al (2008). SEER Cancer Statistics Review, 1975-2005. National Cancer Institute. Bethesda, MD.
  18. Roder D, Wang JX, Zorbas H, Kollias J, Maddern G (2010). Survival from breast cancers managed by surgeons participating in the National Breast Cancer Audit of the Royal Australasian College of Surgeons. ANZ J Surg, 80, 776-80. https://doi.org/10.1111/j.1445-2197.2010.05341.x
  19. Royal Australasian College of Surgeons (RACS) on behalf of Breast Surgeons of Australia and New Zealand (2011). The National Breast Cancer Audit. Data dictionary, updated July 2011. RACS, Adelaide, Australia.
  20. SACR (South Australian Cancer Registry) (1999). Epidemiology of cancer in South Australia. Incidence, mortality and survival 1977 to 1998. Incidence and mortality 1998. Openbook Publishers, Adelaide, Australia.
  21. SACR (South Australian Cancer Registry) Cancer in South Australia 2004 with incidence projections to 2007. Government of South Australia, Adelaide, Australia.
  22. Tousimis E (2005). Synchronous bilateral invasive breast cancer. Breast Cancer Online (www.bco.org) 8 (4), doi: 1017/S1470903 105002075.
  23. Tracey E, Baker D, Chen W, Stavrou E, Bishop J (2007). Cancer in New South Wales: Incidence, mortality and prevalence report 2005. Cancer Institute NSW, Sydney.
  24. Verkooijen HM, Chatelain V, Fioretta G, et al (2007). Survival after bilateral breast cancer: results from a population-based study. Breast Cancer Res Treat, 105, 347-57. https://doi.org/10.1007/s10549-006-9455-x

Cited by

  1. Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies vol.146, pp.3, 2014, https://doi.org/10.1007/s10549-014-3045-0
  2. Influence of Mammographic Screening on Breast Cancer Incidence Trends in South Australia vol.15, pp.7, 2014, https://doi.org/10.7314/APJCP.2014.15.7.3105
  3. Epistaxis as the First Manifestation of Silent Renal Cell Carcinoma: A Case Report with Relevant Literature Review vol.13, pp.1, 2016, https://doi.org/10.5812/iranjradiol.31208
  4. Breast cancer mortality in synchronous bilateral breast cancer patients pp.1532-1827, 2019, https://doi.org/10.1038/s41416-019-0403-z